Skip to content

Taxable Fixed Income

Intermediate Government / Credit Strategy

Performance

As of 3/31/23 Inception Date
QTD YTD 1 Year 3 Year 5 Year 10 Year Since Inception
Glenmede Intermediate Government/Credit (Gross) 2.4% 2.4% -1.2% -1.2% 1.4% 1.3% 3.8% 12/31/1999
Glenmede Intermediate Government/Credit (Net) 2.3% 2.3% -1.5% -1.5% 1.1% 0.9% 3.4%
Bloomberg Intermediate Government/Credit 2.3% 2.3% -1.7% -1.3% 1.4% 1.3% 3.8%

Calendar Year Returns

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Glenmede Gross -7.5% -1.5% 5.9% 6.5% 1.0% 2.2% 1.7% 1.3% 2.7% -0.5% 3.9% 5.6% 5.4% 5.3% 6.9% 7.3% 4.2% 1.7% 3.0% 3.0%
Glenmede Net -7.7% -1.8% 5.5% 6.0% 0.6% 1.8% 1.3% 0.9% 2.3% -0.9% 3.5% 5.2% 5.0% 4.8% 6.5% 6.9% 3.8% 1.3% 2.6% 2.6%
Barclays Intermediate Government/Credit -8.2% -1.4% 6.4% 6.8% 0.9% 2.1% 2.1% 1.1% 3.1% -0.9% 3.9% 5.8% 5.9% 5.2% 5.1% 7.4% 4.1% 1.6% 3.0% 4.3%
Gross +/- 0.8% 0.0% -0.6% -0.3% 0.2% 0.1% -0.4% 0.2% -0.5% 0.3% 0.0% -0.2% -0.5% -1% 1.9% -0.1% 0.1% 0.1% -0.1% -1.3%

 

Performance quoted is past performance and is not a guarantee of future results. Products have fees that reduce their performance, indexes do not. You cannot invest directly in an index. For further information see the Fact Sheet below.

Overview

GIM’s disciplined approach to fixed income management is long-term and risk-averse. GIM seeks to deliver attractive risk-adjusted returns by constructing portfolios that have the potential to provide price stability during periods of interest rate volatility.

This website is for informational purposes only and is not a solicitation for any product or service. GIM products are actively managed and their characteristics will vary. All investment has risk, including the risk of loss of principal. There can be no assurance that efforts to manage risk or to achieve any articulated investment objective will be successful. An investor should consider investment objectives, risks, charges and expenses carefully before investing. For additional information regarding risks and about the firm, please refer to Related Literature and Disclosures.